HARRIS ASSOCIATES L P
Position in CRL — Charles River Laboratories International, Inc.
CIK 813917
CHICAGO, IL
Position in CRL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$508,269,047
+$136,825,487 QoQ
Shares Held
2,241,144
+4.1% QoQ
Ownership
4.69%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#5
of 570 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HARRIS ASSOCIATES L P holds $3,646,085,562 across 6 Diagnostics & Research names. CRL ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
12,183,830 | $2,354,159,631 | |
| 2 | ICLR |
Icon PLC
|
4,468,146 | $776,161,641 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
This page
|
2,241,144 | $508,269,047 | |
| 4 | WAT |
Waters Corp /De/
|
18,413 | $6,905,611 | |
| 5 | DHR |
Danaher Corp /De/
|
1,838 | $350,102 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
455 | $239,530 |
All Filings in CRL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $508,269,047 | 2,241,144 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $371,443,560 | 2,153,296 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $334,648,844 | 1,677,606 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $230,478,722 | 1,473,084 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $176,452,127 | 1,162,935 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||